摘要
维生素D又称抗佝偻病维生素.是一种类固醇激素,主要来源于皮肤经紫外线照射后合成,少数来自于饮食摄取。维生素D只有经过羟化酶的催化才具有生物活性。
出处
《江西医药》
CAS
2012年第10期939-942,共4页
Jiangxi Medical Journal
参考文献18
-
1PittasA G,Sun Q,Manson J E,et al. Plasma 25 -hydroxyvitamin Dconcentration and risk of incident type 2 diabetes in women.Dia-betes Care ,2010, 33:2021.
-
2PamelaR,von Hurst, Welma Stonehouse.Vitamin D supplementationreduces insulin resistance in South Asian women living in NewZealand who are insulin resistant and vitamin D defcient -arandomised, placebo-controlled trial.Nutr,2010,103:549.
-
3TracySMoreira’Mazen J,Hamadeh. The role of vitamin D defciencyin the pathogenesis of type 2 diabetes mellitus. European e -Journal of Clin Nutr and Meta, 2010,5:e 155.
-
4HeidiWolden -Kirk ,Lut Overbergh, Henrik Thybo Christesen.Vitamin D and diabetes: Its importance for beta cell and immunefunction.Molecular and Cellular Endocrinology ,2011,347:106.
-
5RabinovitchA, Suarez -Pinzon WL, Sooy K, et al.Expression ofcalbindin -D (28k) in a pancreatic islet beta -cell line protectsagainst cytokine -induced apoptosis and necrosis. Endocrinology,2001,142:3649.
-
6Dilip K Deb, Yunzi Chen, Zhongyi Zhang, et al. 1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-KB pathway.Physiol Renal Physiol,2009,296(5): F1212.
-
7MarioCozzolino,FlorjanMehmeti, Paola Ciceri,et al. The Effect ofParicalcitol on Vascular Calcifcation and Cardiovascular Diseasein Uremia: Beyond PTH Control.Inj Nephrol,2011, 2011 : 269060.
-
8JohnP Forman, Jonathan S Williams,Naomi DL Fisher. Plasma 25-hydroxyvitamin D and regulation of the Renin Angiotensin Systemin Humans.Hypertension,2010,55(5): 1283.
-
9ZhongyiZhang, Yan Zhang, Gang Ning, et al. Combination therapywith ATI blocker and vitamin D analog markedly amelioratesdiabetic nephropathy:Blockade of compensatory renin increase.PNAS ,2008,14:15896.
-
10Ikko Ohara, Mitsuo Tanimoto, Tomohito Gohda. Effect ofCombination Therapy with Angiotensin Receptor Blocker and 1,25 -Dihydroxyvitamin D3 in Type 2 Diabetic Nephropathy in KK-iVy/Ta Mice.Nephron Exp Nephrol,2011,117:el24.
同被引文献98
-
1张春,朱忠华,刘建社,杨晓,邓安国.结缔组织生长因子对肾小管上皮细胞转分化的调节机制[J].中华医学杂志,2005,85(41):2920-2925. 被引量:22
-
2周月宏,王秋月.CTGF在糖尿病肾病发病机制中的作用及意义[J].国际内分泌代谢杂志,2006,26(4):273-276. 被引量:20
-
3杨勤,谢汝佳,韩冰,肖瑛,杨婷,方丽,龙义国,张国忠.转化生长因子胞内信号蛋白Smad2/3在糖尿病大鼠肾脏表达的动态观察及意义研究[J].中国病理生理杂志,2006,22(10):1879-1884. 被引量:21
-
4Martinez-Salgado C, Fuentes-Calvo I, Garcia-Cenador B, et al. Involvement of H- and N-Ras isoforms in transforming growth factor- betal-induced proliferation and in collagen and fibronectin synthesis [ J]. Exp Cell Res, 2006,312( 11 ) :2093-2106.
-
5Kattla JJ, Carew RM, Heljic M, et al. Protein kinase B/Akt activity is involved in renal TGF-betal-driven epithelial-mesenchymal transition in vitro and in vivo [ J ]. Am J Physiol Renal Physiol, 2008,295 ( 1 ) : F215-F225.
-
6Lee TN, Alborn WE, Knierman MD, et al. The diabetogenic antibiotic streptozotocin modifies the tryptic digest pattern for peptides of the enzyme O-GlcNAc-selective N-acetyl-beta-d-glucosaminidase that contain amino acid residues essential for enzymatic activity [ J ]. Biochem Pharmacol, 2006,72 ( 6 ) :710-718.
-
7Evans JL, Goldfine ID, Maddux BA, et al. Oxidative stress and stress- activated signaling pathways : a unifying hypothesis of type 2 diabetes [J]. Endocr Rev, 2002,23(5) :599-622.
-
8Ziyadeh FN. Mediators of diabetic renal disease : the ease for TGF-beta as the major mediator[ J]. J Am Soc Nephrol, 2004,15 ( Suppl 1 ) : $55-$57.
-
9Fraser D, Brunskill N, Ito T, et al. Long-term exposure of proximal tubular epithelial cells to glucose induces transforming growth factor- beta 1 synthesis via an autoerine PDGF loop J . Am J Pathol, 2003, 163 ( 6 ) :2565-2574.
-
10Karakus SC, Turkyilmaz Z, Sonmez K, et al. The effect of enalapril on renal resistive index, urine electrolyte levels and TGF-betal levels of kidney tissues in rats with unilateral partial ureteropelvic junction obstruction[ J]. Eur J Pediatr Surg, 2011,21 (6) :356-361.
引证文献6
-
1范乐平,林静娜.维生素D与糖尿病肾病的研究进展[J].转化医学杂志,2014,3(1):59-62. 被引量:5
-
2蔡璐.骨化三醇治疗血液透析患者继发性甲状旁腺功能亢进的疗效观察[J].江西医药,2014,49(6):529-531. 被引量:8
-
3齐新颜.老年2型糖尿病伴高血压患者血清25羟维生素D的变化及临床意义[J].中国实用医药,2014,9(26):110-110. 被引量:1
-
4杨烨,张园园,田燕燕,俞瑞,吕国栋,肖拉提,朱佳,朱筠.活性维生素D3对糖尿病肾病大鼠转化生长因子β1及相关因子的调节作用[J].中华内分泌代谢杂志,2015,31(1):66-70. 被引量:11
-
5权志慧,夏成云.维生素D与慢性肾脏病的研究进展[J].国际泌尿系统杂志,2015,35(3):472-475. 被引量:1
-
6马红雨,董磊,孙立美,李瑞琦.维生素D与糖尿病肾病相关作用机制的研究进展[J].空军医学杂志,2017,33(4):283-285. 被引量:8
二级引证文献34
-
1李凯宇.骨化三醇治疗血液透析患者继发性甲状旁腺功能亢进的疗效观察[J].中外女性健康研究,2015,0(4):220-220. 被引量:1
-
2向茜,李万碧,白云霞,郭燕,张弦,张永新,杨才,李勇军.25羟维生素D与2型糖尿病肾病的关系[J].昆明医科大学学报,2015,36(5):74-78.
-
3季菲,肖海燕,胡晓梅.邓成珊攻补兼施治疗原发性骨髓纤维化经验[J].世界中医药,2015,10(7):1026-1029. 被引量:3
-
4张威,田少江.羟苯磺酸钙对糖尿病肾病患者血清25-羟基维生素D表达的影响[J].检验医学与临床,2015,12(20):3000-3002. 被引量:3
-
5武建虎,郭青,刘冬妍,张楠,尤伟杰.科技学术期刊编辑交叉审读的意义及应注意的“5性”[J].编辑学报,2019,0(5):506-508. 被引量:1
-
6祝匡明,高新庐.不同剂量的骨化三醇冲击治疗血液透析继发甲旁亢的疗效分析[J].江西医药,2015,50(12):1446-1447. 被引量:4
-
7吴学敏,唐新征,刘学耀.益气化瘀法对糖尿病肾病大鼠PI3K/Akt通路影响的实验研究[J].四川中医,2016,34(1):48-51. 被引量:12
-
8金尚福.骨化三醇冲击治疗慢性肾病继发性甲状旁腺功能亢进症的临床疗效观察[J].中国基层医药,2016,23(1):140-143. 被引量:2
-
9徐园园,魏迎凤,卢学超,解其华,翟林云.活性维生素D_3灌胃治疗大鼠糖尿病肾病的效果及其作用机制[J].山东医药,2016,56(3):31-33. 被引量:2
-
10闫冰,黄盛玲,管保章.骨化三醇冲击治疗尿毒症继发性甲状旁腺功能亢进疗效的Meta分析[J].内科,2016,11(1):76-78. 被引量:2
-
1杨冰冰,陈熙.维生素D与非酒精性脂肪性肝病[J].国际消化病杂志,2013,33(6):380-383. 被引量:1
-
2张利伯,车炳坤,孙岳仑,戴玉林,阎中集,侯文阁,徐景跃,毕惠芳,施鹏飞,艾全枢,林亚哲,秦德生.东北地区冬季阳光抗佝偻病作用的实验研究[J].环境与健康杂志,1992,9(2):53-55.
-
3柏长青,常雁军,战兴利,彭瑞芳.二种内固醇激素制剂治疗重症哮喘的对比研究[J].临床荟萃,1999,14(1):1-2. 被引量:30
-
4两种类固醇激素在急性感染性疾病中的作用[J].传染病网络动态,2004(12):38-40.
-
5田勇.抗佝偻病治疗婴幼儿迁延性腹泻[J].儿科药学,2000,6(3):33-33. 被引量:2
-
6崔树明.维生素D与2型糖尿病相关性研究进展[J].医学理论与实践,2013,26(19):2554-2556.
-
7王亚平,任超.紫外线抗佝偻病的机制及紫外线疗法[J].锦州医学院学报,1997,18(4):45-46.
-
8肖甜甜,左嵩,周雯倩,郝守艳,秦聪,郑杨.维生素D与心血管系统疾病[J].中国老年学杂志,2014,34(6):1713-1715. 被引量:2
-
9张秀琴,武广云.高热惊厥与偻病关系的研究[J].交通医学,1995,9(2):25-26.
-
10卫志干.类固醇激素诱发结核病38例临床分析[J].实用医技杂志,2004,11(12A):2537-2538.